Papers/PMID:35918728
The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.
Reproductive biology and endocrinology : RB&E2022The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
magnesium(2+) — increases health-related quality of life
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After adjusting for baseline serum magnesium and initial measurements, magnesium supplementation improved scores of role limitations due to emotional problems (p = 0.001), energy/fatigue (p = 0.010), emotional wellbeing (p < 0.001), general health (p = 0.042), and total quality of life (p < 0.001) compared with placebo.”
Quoted verbatim from The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.. - Study
- RCT
- Duration
- 2 months
- Dose
- 250 mg magnesium oxide tablet per day
- Population
- Women aged 18 to 45 with polycystic ovary syndrome, intention-to-treat; both arms received the same dietary recommendations; ANCOVA adjusted for baseline serum magnesium, energy intake and baseline values
The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial.2022PMID:35918728Permalink